A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Brigatinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Brigatinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Brigatinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Brigatinib Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Brigatinib 13C6 Stable Isotopes CS-EK-02077 1197953-54-0 unlabeled Enquire
Brigatinib D11 Stable Isotopes CS-EO-02947 2055306-76-6 Enquire
Brigatinib D3 Stable Isotopes CS-EO-02945 2055306-71-1 Enquire
Brigatinib-d6 Stable Isotopes CS-O-44730 Not Available Enquire


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Brigatinib API Standards CS-EK-01749 1197953-54-0 Enquire


Intermediates

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
1-Methyl-4-piperidin-4-yl-piperazine (Brigatinib impurity) Intermediates CS-M-43629 53617-36-0 Enquire


Glucuronides

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Brigatinib-d5 Glucuronides CS-O-44728 Not Available Enquire